Is the Fortescue (ASX:FMG) share price dirt cheap or overvalued?

Where next for Fortescue shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fortescue Metals Group Limited (ASX: FMG) share price was a positive performer on Monday.

The mining giant's shares rose 2% to end the day at $15.80.

This means the Fortescue share price is now up approximately 9% since this time last month.

a man in a hard hat and checkered shirt holds paperwork in one hand as he holds his hands upwards in an enquiring manner as though asking a question or exasperated by uncertainty.

Image source: Getty Images

Is the Fortescue share price a bargain buy?

Opinion on the Fortescue share price continues to be highly divisive, with some brokers believing its shares are vastly overvalued and others believing them to be dirt cheap.

In respect to the latter, the team at Bell Potter continue to see a lot of value in the Fortescue share price.

A recent note reveals that its analysts have a buy rating and $19.75 price target on its shares. This implies potential upside of 25% for investors over the next 12 months.

In addition, the broker expects the iron ore miner to pay a $3.07 per share fully franked dividend in FY 2022. This equates to a very attractive fully franked yield of 19.4%, which stretches the total potential return to almost 45%.

In response to its first quarter update, Bell Potter said: "Strong free cash flows, good cost control and an 'on-track' production performance emphasise the quality of the business and we retain our Buy recommendation."

What about the bears?

One of the most bearish brokers out there is Goldman Sachs. This morning the broker retained its sell rating and $11.00 price target on the company's shares. Based on the current Fortescue share price, this implies potential downside of just over 30% for investors.

There are four key reasons why Goldman is bearish on Fortescue. These include its relative valuation, the widening of low grade iron ore discounts, execution and ramp up risks on the Iron Bridge project, and uncertainties around Fortescue Future Industries (FFI) diversification and Pilbara decarbonisation.

In respect to the latter, the broker believes decarbonising the Pilbara could cost Fortescue over US$7 billion and requires +US$50 per tonne carbon or a green premia to be NPV positive.

Goldman concluded: "We have an Underperform rating on FMGAU. In our view, FMGAU is set to face headwinds from lower iron ore prices and remains an unlikely IG upgrade candidate due to its concentrated portfolio (single-commodity exposure in one region of Australia) and the strategic uncertainty implied by its openness to entering other markets (e.g. renewables). The company is facing execution risk at Iron Bridge from increased project capex and a team reorganization."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares Macquarie says will return 23% to 49%

These shares are well-positioned for a strong year.

Read more »

Woman and man at work looking at data on a tablet at work.
Broker Notes

Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares

Amid another day in the green for the ASX 200, experts reveal their new ratings.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

This ASX small-cap healthcare stock is tipped to double in value

This company has a good base to build on.

Read more »

Woman looking at her computer and pondering something.
Broker Notes

What is this broker's updated view on PLS shares after big results?

Where to next for this red hot stock?

Read more »

Senior man looking at his laptop and pondering something.
Broker Notes

Buy, hold, sell: Deterra Royalties, GQG Partners, and TPG Telecom shares

Morgans has updated its views on these popular stocks.

Read more »